| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.90B | 39.28B | 33.53B | 30.11B | 27.04B | 24.51B |
| Gross Profit | 23.27B | 26.72B | 23.00B | 20.66B | 18.59B | 16.84B |
| EBITDA | 4.07B | 4.50B | 4.11B | 3.59B | 3.01B | 2.14B |
| Net Income | 2.19B | 2.52B | 2.31B | 2.09B | 1.65B | 1.04B |
Balance Sheet | ||||||
| Total Assets | 25.93B | 31.60B | 26.39B | 23.79B | 21.27B | 19.05B |
| Cash, Cash Equivalents and Short-Term Investments | 3.01B | 3.31B | 3.01B | 3.02B | 2.91B | 2.60B |
| Total Debt | 5.07B | 6.35B | 3.18B | 2.43B | 2.15B | 2.25B |
| Total Liabilities | 8.19B | 11.27B | 8.02B | 6.79B | 5.92B | 5.30B |
| Stockholders Equity | 17.63B | 20.22B | 18.27B | 16.90B | 15.28B | 13.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.19B | 822.66M | 737.75M | 1.13B | 963.62M |
| Operating Cash Flow | 0.00 | 2.47B | 2.14B | 1.87B | 1.77B | 1.48B |
| Investing Cash Flow | 0.00 | -2.71B | -1.84B | -1.20B | -820.75M | -219.54M |
| Financing Cash Flow | 0.00 | 521.42M | -334.41M | -587.97M | -714.03M | -899.69M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.12B | 12.04 | ― | 2.19% | 15.14% | 17.01% | |
79 Outperform | ¥32.99B | 10.78 | ― | 3.77% | 17.14% | 8.81% | |
74 Outperform | ¥35.67B | 5.26 | ― | 1.73% | 7.61% | 57.19% | |
66 Neutral | ¥19.19B | 14.00 | ― | 3.53% | -1.39% | -15.64% | |
66 Neutral | ¥31.08B | 4.74 | ― | 0.95% | 15.82% | ― | |
65 Neutral | ¥234.96B | 14.06 | ― | 0.64% | 53.35% | 107.20% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |